The research interests of Dusica Babovic-Vuksanovic, M.D., include overgrowth syndromes, as well as various genetic syndromes and metabolic disorders. Her research involves several collaborative basic research studies in the field of neurofibromatosis, in conjunction with Mayo's Neuro-Oncology Program and departments of Radiology and Neurologic Surgery.
- Neurofibromatosis. Dr. Babovic-Vuksanovic holds a leadership role in collaborative studies looking at children, adolescents and young adults with neurofibromatosis 1 and progressive plexiform neurofibromas as well as adult patients with neurofibromatosis 1 and extensive plexiform and paraspinal neurofibromas.
- Spontaneous coronary artery dissection (SCAD). Dr. Babovic-Vuksanovic is part of a multidisciplinary team carrying out patient-initiated research regarding SCAD, a nonatherosclerotic abnormality of the heart artery in which obstruction of blood flow to the heart occurs due to splitting of the vessel walls.
Significance to patient care
Dr. Babovic-Vuksanovic's research works toward a better understanding of various genetic syndromes and metabolic disorders, thereby contributing to improved diagnosis, treatment and outcomes for patients with these conditions.
- Funding recipient: Neurofibromatosis biobank pilot award, Children's Tumor Foundation and the Food and Drug Administration, 2011-2015
- Instructor, Basic Life Support course, pediatric clinic, Bosnian-Herzegovinian American Academy of Arts and Sciences, Banja Luka, Bosnia and Herzegovina, 2012
- Funding recipient: Neurofibromatosis clinic; Children's Tumor Foundation, NF Clinic Network; 2008-2009
- Funding recipient: Phase I/Phase II Trial of Pirfenidone in Children with Neurofibromatosis 1 and Plexiform Neurofibromas, U.S. Department of Defense, 2002-2008
- Editorial board, Journal of Pediatric Neurology, 2007